Starpharma Holdings (Starpharma Holdings) Inventories, Finished Goods : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Starpharma Holdings Inventories, Finished Goods?

Starpharma Holdings's quarterly finished goods increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($0.13 Mil) but then declined from Jun. 2023 ($0.13 Mil) to Dec. 2023 ($0.00 Mil).

Starpharma Holdings's annual finished goods declined from Jun. 2021 ($0.57 Mil) to Jun. 2022 ($0.18 Mil) and declined from Jun. 2022 ($0.18 Mil) to Jun. 2023 ($0.13 Mil).

Starpharma Holdings Inventories, Finished Goods Historical Data

The historical data trend for Starpharma Holdings's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Inventories, Finished Goods Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.11

0.57

0.18

0.13

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventories, Finished Goods	Get a 7-Day Free Trial															-	0.18	-	0.13	-

Starpharma Holdings Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

SPHRF:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.